Dietary Fiber and Time Restricted Eating (FIBER+TRE)

July 1, 2026 updated by: University of Oklahoma

Examining the Independent and Combined Effects of Dietary Fiber and Time Restricted Eating on Indicators of Cancer Risk: the Fiber and Time Restricted Eating (F.I.T.) Study

This study is seeking to examine combinations of two different dietary interventions on cancer risk.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

90

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ohio
      • Columbus, Ohio, United States, 43230
        • University of Oklahoma Health Sciences

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • ≥18 age
  • Body mass index ≥30 kg/m2
  • Dietary fiber intake ≤15 g/day
  • Compatible cell phone for use of ecological momentary assessment app

Exclusion Criteria:

  • Self-reported diagnosis that precludes fiber intake (e.g., inflammatory bowel disease)
  • Food allergies or intolerances that limit ability to engage with the intervention
  • Positive screen on the SCOFF eating disorder screener39
  • Current self-reported use of GLP-1 receptor agonists
  • Currently pregnant or breastfeeding, or planning to become pregnant

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Factorial Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Time Restricted Eating (TRE)
10-hour Time Restricted Eating (TRE)
Experimental: Fiber for Improvement of Behavior, Eating, and Risk (FIBER)
Group education about dietary fiber
Counseling and motivational interviewing to promote uptake of diet changes
Experimental: FIBER and TRE
Group education about dietary fiber
Counseling and motivational interviewing to promote uptake of diet changes
10-hour Time Restricted Eating (TRE)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Dietary fiber intake
Time Frame: Baseline, post-intervention (approximately 3 months), and post-observation (approximately 12 months)
Dietary fiber intake as reported on 3-day diet records and analyzed according to Nutrition Data System for Research; reported as a mean intake over three days in grams per day
Baseline, post-intervention (approximately 3 months), and post-observation (approximately 12 months)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Body mass/weight
Time Frame: Baseline, post-intervention (approximately 3 months), and post-observation (approximately 12 months)
Body mass/weight will be measured in kilograms
Baseline, post-intervention (approximately 3 months), and post-observation (approximately 12 months)
Blood-based measures of inflammation
Time Frame: Baseline, post-intervention (approximately 3 months), and post-observation (approximately 12 months)
Venous blood samples will be collected and analyzed for inflammatory markers: Granulocyte-macrophage colony-stimulating factor (GM-CSF), interferon-gamma (IFN-γ), interleukin-1 beta (IL-1β), interleukin-2 (IL-2), interleukin-4 (IL-4), interleukin-5 (IL-5), interleukin-6 (IL-6), interleukin-8 (IL-8), interleukin-10 (IL-10), and tumor necrosis factor-alpha (TNF-α).
Baseline, post-intervention (approximately 3 months), and post-observation (approximately 12 months)
Blood-based measures of oxidative stress
Time Frame: Baseline, post-intervention (approximately 3 months), and post-observation (approximately 12 months)
Venous blood samples will be collected and analyzed for measures of oxidative stress, including reactive oxygen species and lipid peroxidation
Baseline, post-intervention (approximately 3 months), and post-observation (approximately 12 months)
Blood-based measures of insulin resistance
Time Frame: Baseline, post-intervention (approximately 3 months), and post-observation (approximately 12 months)
Insulin resistance will be measured via assessment of insulin and glucose in venous blood samples, and used to assess Homeostatic Model Assessment of Insulin Resistance (HOMA-IR)
Baseline, post-intervention (approximately 3 months), and post-observation (approximately 12 months)
Affect
Time Frame: Daily for three months
Self-reported affect will be assessed using ecological momentary assessment, delivered via cell phone
Daily for three months
Sleep
Time Frame: Daily for three months
Sleep will be measured via Fitbits, assessed as mean minutes/night
Daily for three months
Physical Activity
Time Frame: Daily for three months
Physical activity will be measured via Fitbits, assessed as mean steps/day
Daily for three months
Blood pressure
Time Frame: Baseline, post-intervention (approximately 3 months), and post-observation (approximately 12 months)
Blood pressure (systolic and diastolic) will be measured at each time frame (in millimeters of mercury [mmHg])
Baseline, post-intervention (approximately 3 months), and post-observation (approximately 12 months)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 10, 2025

Primary Completion (Estimated)

June 30, 2027

Study Completion (Estimated)

June 30, 2027

Study Registration Dates

First Submitted

October 20, 2025

First Submitted That Met QC Criteria

October 20, 2025

First Posted (Actual)

October 22, 2025

Study Record Updates

Last Update Posted (Actual)

July 6, 2026

Last Update Submitted That Met QC Criteria

July 1, 2026

Last Verified

July 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cancer Prevention

Clinical Trials on Group education

3
Subscribe